Zhen Marianne

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return11%5%17%7%0%
Sale Success Rate2 of 42 of 42 of 41 of 40 of 4

Theravance Inc.

Drugs » Biotechnology

Chief Accounting Officer:

Holdings: 45.62K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--